EBV specific CTLs (Baylor College of Medicine)

N/A

Report date: 2022/12/31 20:52:38

Base Information

Drug NameEBV specific CTLs (Baylor College of Medicine)
Drug Alias Name14g2a.zeta Chimeric Recep Transduc (EBV-CTL) w/o Lymphodepl
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A